ModivCare (MODV) Free Cash Flow Misrepresentation Case

• $MODV investors filed a lawsuit against ModivCare, alleging the company misled them about its financial stability and cash flow.

• On September 12, 2024, ModivCare disclosed liquidity concerns and announced plans to seek additional capital. Following this news, $MODV stock dropped 59%​.

• $MODV investors can join this case to be notified about potential recovery.

Case Details:

Between November 3, 2022, and September 15, 2024, ModivCare assured investors that its non-emergency medical transportation (NEMT) contracts provided stable revenue and minimized financial risks. The company claimed that shifting from full-risk contracts to shared-risk agreements was improving its finances, protecting profit margins, and keeping cash flow strong.

However, throughout 2023 and 2024, ModivCare’s cash flow worsened due to contract renegotiations, pricing changes, and rising costs. Despite these struggles, the company continued to project a positive financial outlook to investors.

On September 12, 2024, ModivCare admitted it was facing serious liquidity problems and needed to raise additional capital to keep operating. This news caused $MODV to drop 59%.

A few days later, on September 16, 2024, the company lowered its earnings forecast for the year, revealing that contract pricing adjustments had severely hurt its profits, leading to another 10% drop in $MODV.

Based on these events, $MODV investors filed a lawsuit against ModivCare, claiming the company:

• Misled investors about the financial stability of its NEMT contracts.

• Downplayed liquidity risks and the impact of contract renegotiations on free cash flow.

Investors believe ModivCare misled them about its financial stability and downplayed liquidity risks.